Financial Enhancement Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-23
| Closed | -$1K | – | 307 |
|
|
2021
Q4 | $1K | Buy |
+23
| New | +$1K | ﹤0.01% | 251 |
|
|
2020
Q4 | – | Sell |
-800
| Closed | -$48K | – | 285 |
|
|
2020
Q3 | $48K | Hold |
800
| – | – | 0.01% | 123 |
|
|
2020
Q2 | $47K | Buy |
+800
| New | +$47K | 0.01% | 129 |
|
|
2018
Q2 | – | Sell |
-1,424
| Closed | -$90K | – | 249 |
|
|
2018
Q1 | $90K | Buy |
+1,424
| New | +$90K | 0.03% | 106 |
|